| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	4-PBA
				
			5-ASA
				
				
					Thrombocytopenia: very rare, postmarketing 5-FU
				
			5-aminolevulinic acid
				
			5-aza-2'-deoxycytidine
				
				
					Thrombocytopenia: 24% - 89.2% 5-azacytidine
				
				
					Thrombocytopenia: very common, 3.2% - 69.7% 5-fluorocytosine
				
			6-mercaptopurine
				
			6-thioguanine
				
			A77 1726
				
			APAs
				
			Anidulafungin
				
			BCNU
				
			BPTI
				
			Benicar-HCT
				
			Bivalirudin
				
				
					Thrombocytopenia: postmarketing, 0.3% - 1.1% CAS 76095-16-4
				
			CAS 76420-72-9
				
				
					Thrombocytopenia: postmarketing CGP 19835A
				
			Cancidas
				
				
					Thrombocytopenia: uncommon Carfilzomib
				
				
					Thrombocytopenia: 10.3% - 36.3% D-penicillamine
				
			EACA
				
			Enfuvirtide
				
			Eptifibatide
				
				
					Thrombocytopenia: postmarketing, uncommon, 0.192% - 0.2% FAMP
				
			FK463
				
				
					Thrombocytopenia: 3.96% - 77.1% FdUrd
				
			Ge-132
				
			Glat copolymer
				
				
					Thrombocytopenia: postmarketing Goserelin
				
			K779
				
				
					Thrombocytopenia: postmarketing, 1% - 7% L-Dmp
				
				
					Thrombocytopenia: postmarketing, rare LMWH
				
				
					Thrombocytopenia: postmarketing, 1.5% - 2.8% LY146032
				
			Lisinopril
				
				
					Thrombocytopenia: very rare, postmarketing MDV3100
				
			Madopar
				
			Mersyndol
				
			NSC 352122
				
			NTBC
				
			Octreotide
				
				
					Thrombocytopenia: postmarketing PCI-32765
				
			PGE1
				
			Romidepsin
				
				
					Thrombocytopenia: 0% - 72.3% SU5416
				
			Saxagliptin
				
			Stalevo 50
				
			Supremon
				
			T-A2-3
				
			Timentin
				
			UDCA
				
				
					Thrombocytopenia: postmarketing VACV
				
				
					Thrombocytopenia: very rare, postmarketing, rare, 0.1% - 5% Vancocine
				
				
					Thrombocytopenia: postmarketing Zyprexa Relprevv
				
				
					Thrombocytopenia: very rare abacavir
				
			abacavir-lamivudine
				
				
					Thrombocytopenia: uncommon acamprosate
				
				
					Thrombocytopenia: infrequent acarbose
				
				
					Thrombocytopenia: postmarketing acetaminophen
				
				
					Thrombocytopenia: postmarketing acetazolamide
				
			actinomycin D
				
			acyclovir
				
				
					Thrombocytopenia: very rare, postmarketing adefovir dipivoxil
				
			albendazole
				
			alfuzosin
				
				
					Thrombocytopenia: postmarketing allopurinol
				
			alpha-methyl-p-tyrosine
				
			amiodarone
				
				
					Thrombocytopenia: postmarketing, 1.57% - 1.72% amitriptyline
				
			amlodipine
				
			amlodipine besylate
				
			amoxapine
				
				
					Thrombocytopenia: postmarketing amoxicillin
				
				
					Thrombocytopenia: very rare, postmarketing amphotericin B
				
				
					Thrombocytopenia: 5.8% - 12.8% ampicillin
				
			amsacrine
				
			anagrelide
				
			anthracycline
				
			apixaban
				
				
					Thrombocytopenia: uncommon aprepitant
				
			aripiprazole
				
				
					Thrombocytopenia: uncommon arsenic
				
			arsenic trioxide
				
			asenapine
				
			aspirin
				
			atenolol
				
				
					Thrombocytopenia: postmarketing atorvastatin
				
				
					Thrombocytopenia: postmarketing atovaquone
				
				
					Thrombocytopenia: postmarketing auranofin
				
				
					Thrombocytopenia: postmarketing, 0.9% - 2.2% axitinib
				
			azathioprine
				
			azithromycin
				
				
					Thrombocytopenia: postmarketing aztreonam
				
			belinostat
				
				
					Thrombocytopenia: 7% - 16% benazepril
				
			benazeprilat
				
			bendamustine
				
			bendrofluazide
				
			benzathine penicillin
				
			betaxolol
				
			bexarotene
				
			bezafibrate
				
			bicalutamide
				
			bisoprolol
				
			bleomycin hydrochloride
				
			boceprevir
				
				
					Thrombocytopenia: postmarketing, common bortezomib
				
				
					Thrombocytopenia: 1.2% - 55% bosentan
				
				
					Thrombocytopenia: postmarketing, uncommon bosutinib
				
				
					Thrombocytopenia: 25.4% - 41% bromcresol green
				
			bumetanide
				
			bupropion
				
				
					Thrombocytopenia: postmarketing buspirone
				
			busulfan
				
			cabazitaxel
				
				
					Thrombocytopenia: 2% - 47.4% cabozantinib
				
				
					Thrombocytopenia: 0% - 35% candesartan
				
				
					Thrombocytopenia: postmarketing candesartan cilexetil
				
			capecitabine
				
				
					Thrombocytopenia: 1% - 24% capreomycin
				
			captopril
				
			carbamazepine
				
				
					Thrombocytopenia: very rare, common carbenicillin
				
			carbidopa
				
			carbimazole
				
			carbinoxamine
				
			carboplatin
				
			carvedilol
				
				
					Thrombocytopenia: 0.1% - 2% cefaclor
				
				
					Thrombocytopenia: postmarketing cefadroxil
				
			cefazolin
				
			cefdinir
				
				
					Thrombocytopenia: postmarketing cefditoren
				
				
					Thrombocytopenia: postmarketing cefepime
				
				
					Thrombocytopenia: postmarketing cefixime
				
				
					Thrombocytopenia: postmarketing cefotaxime
				
				
					Thrombocytopenia: postmarketing cefotetan
				
			cefoxitin
				
			cefpodoxime
				
			cefprozil
				
			ceftaroline
				
			ceftazidime
				
				
					Thrombocytopenia: uncommon ceftizoxime
				
			ceftriaxone
				
				
					Thrombocytopenia: postmarketing cefuroxime
				
				
					Thrombocytopenia: postmarketing cefuroxime axetil
				
			celecoxib
				
			cephalexin
				
			cerivastatin
				
			cetirizine
				
				
					Thrombocytopenia: postmarketing cevimeline
				
			chlorambucil
				
			chloramphenicol
				
			chloroquine
				
			chlorpheniramine
				
			chlorpropamide
				
			chlorthalidone
				
			choline theophyllinate
				
			cidofovir
				
			cilazapril
				
				
					Thrombocytopenia: postmarketing cilostazol
				
				
					Thrombocytopenia: postmarketing cimetidine
				
			cinoxacin
				
			ciprofloxacin
				
				
					Thrombocytopenia: postmarketing, rare, uncommon cisplatin
				
			citalopram
				
				
					Thrombocytopenia: postmarketing cladribine
				
				
					Thrombocytopenia: very common, 6% - 12% clarithromycin
				
				
					Thrombocytopenia: postmarketing clemastine
				
			clindamycin
				
			clindamycin phosphate
				
			clobazam
				
				
					Thrombocytopenia: postmarketing clofarabine
				
				
					Thrombocytopenia: 79.8% - 80.7% clomipramine
				
				
					Thrombocytopenia: very rare clonazepam
				
			clonidine
				
			clozapine
				
				
					Thrombocytopenia: postmarketing colchicine
				
				
					Thrombocytopenia: postmarketing copolymer 1
				
				
					Thrombocytopenia: postmarketing cyclobenzaprine
				
				
					Thrombocytopenia: postmarketing cyclophosphamide
				
			cyproheptadine
				
			cyproterone
				
			cyproterone acetate
				
			cytarabine
				
				
					Thrombocytopenia: 5% - 32.1% d-telaprevir
				
			dabigatran
				
				
					Thrombocytopenia: postmarketing dabigatran etexilate
				
				
					Thrombocytopenia: uncommon dabrafenib
				
				
					Thrombocytopenia: 0% - 31% dacarbazine
				
			dalbavancin
				
			dalteparin
				
			danazol
				
			dantrolene
				
			darunavir
				
			dasatinib
				
				
					Thrombocytopenia: postmarketing, 5% - 85% deferasirox
				
				
					Thrombocytopenia: postmarketing deferoxamine
				
				
					Thrombocytopenia: very rare delamanid
				
			delavirdine
				
			demeclocycline
				
			deprenyl
				
			desipramine
				
			dexamethasone
				
			dexmedetomidine
				
			dexrazoxane
				
			diatrizoate
				
			diazepam
				
			diazoxide
				
			dichlorphenamide
				
			diclofenac
				
				
					Thrombocytopenia: very rare dicloxacillin
				
			didanosine
				
				
					Thrombocytopenia: postmarketing diflunisal
				
			digoxin
				
			diltiazem
				
				
					Thrombocytopenia: postmarketing diphenhydramine
				
			dipyridamole
				
			disopyramide
				
			dobutamine
				
			docetaxel
				
				
					Thrombocytopenia: rare, 0% - 47% dolasetron
				
			donepezil
				
				
					Thrombocytopenia: infrequent doripenem
				
				
					Thrombocytopenia: postmarketing, uncommon Thrombocytopenia toxic: postmarketing dothiepin
				
			doxazosin
				
				
					Thrombocytopenia: postmarketing doxepin
				
			doxorubicin
				
				
					Thrombocytopenia: uncommon, common, very common, 0% - 51.4% doxycycline
				
				
					Thrombocytopenia: postmarketing doxycycline calcium
				
			doxycycline hyclate
				
			duloxetine
				
				
					Thrombocytopenia: postmarketing, infrequent efavirenz
				
			emtricitabine
				
				
					Thrombocytopenia: postmarketing entacapone
				
			eprosartan
				
			eribulin
				
			erlotinib
				
			ertapenem
				
			eslicarbazepine acetate
				
			esomeprazole magnesium
				
			estramustine
				
				
					Thrombocytopenia: 1% - 2% estramustine phosphate
				
				
					Thrombocytopenia: 1% - 2% ethacrynic acid
				
			ethambutol
				
			ethionamide
				
			etodolac
				
			etoposide
				
			etoposide phosphate
				
			etoricoxib
				
				
					Thrombocytopenia: postmarketing etravirine
				
			everolimus
				
				
					Thrombocytopenia: common, very common, 0% - 19% exemestane
				
			ezetimibe
				
				
					Thrombocytopenia: postmarketing famciclovir
				
				
					Thrombocytopenia: very rare, postmarketing, rare famotidine
				
			febuxostat
				
			felbamate
				
				
					Thrombocytopenia: infrequent fenofibrate
				
			fenoprofen
				
			fentanyl
				
			flecainide
				
			flucloxacillin
				
				
					Thrombocytopenia: very rare fluconazole
				
				
					Thrombocytopenia: postmarketing fludarabine
				
			fluoxetine
				
				
					Thrombocytopenia: postmarketing, rare flurbiprofen
				
			flutamide
				
			fluticasone
				
				
					Thrombocytopenia: postmarketing fluvastatin
				
				
					Thrombocytopenia: very rare, postmarketing fluvoxamine
				
				
					Thrombocytopenia: rare, infrequent fondaparinux
				
				
					Thrombocytopenia: postmarketing, uncommon foscarnet
				
			fosinopril
				
			fosinoprilat
				
			fosphenytoin
				
				
					Thrombocytopenia: infrequent fotemustine
				
			furosemide
				
				
					Thrombocytopenia: uncommon fusidic acid
				
			gabapentin
				
				
					Thrombocytopenia: postmarketing, infrequent gadolinium
				
			gadoversetamide
				
			galantamine
				
				
					Thrombocytopenia: rare, infrequent ganciclovir
				
				
					Thrombocytopenia: 5% - 6.6% gatifloxacin
				
				
					Thrombocytopenia: postmarketing gefitinib
				
			gemcitabine
				
				
					Thrombocytopenia: postmarketing, very common, 1% - 57% gemfibrozil
				
			gemifloxacin
				
			gentamicin
				
			glibenclamide
				
			gliclazide
				
			glimepiride
				
				
					Thrombocytopenia: postmarketing glipizide
				
				
					Thrombocytopenia: postmarketing gold sodium thiomalate
				
			granisetron
				
			guanidinium
				
			haloperidol
				
				
					Thrombocytopenia: very rare, postmarketing hemin
				
				
					Thrombocytopenia: postmarketing heparin
				
			hepatitis B vaccines
				
			hexamethylmelamine
				
			histamine
				
			hydralazine
				
				
					Thrombocytopenia: uncommon hydrochlorothiazide
				
			hydrocodone
				
			hydroflumethiazide
				
			hydroxychloroquine
				
			hydroxyurea
				
				
					Thrombocytopenia: common, 1-5% ibuprofen
				
			icodextrin
				
				
					Thrombocytopenia: postmarketing idarubicin
				
			ifosfamide
				
			iloprost
				
				
					Thrombocytopenia: postmarketing imatinib
				
				
					Thrombocytopenia: postmarketing, very common, 0% - 97.8% imipramine
				
				
					Thrombocytopenia: very rare indapamide
				
			indinavir
				
			indomethacin
				
			iodide
				
			irbesartan
				
				
					Thrombocytopenia: postmarketing irbesartan-hydrochlorothiazide
				
			irinotecan
				
				
					Thrombocytopenia: 0% - 98.6% isomannide
				
			isoniazid
				
			isosorbide-5-mononitrate
				
			isradipine
				
			itraconazole
				
				
					Thrombocytopenia: postmarketing ixabepilone
				
				
					Thrombocytopenia: 2% - 5% ketoconazole
				
				
					Thrombocytopenia: postmarketing ketoprofen
				
			ketorolac
				
				
					Thrombocytopenia: postmarketing ketorolac tromethamine
				
				
					Thrombocytopenia: postmarketing ketotifen
				
			lamivudine
				
				
					Thrombocytopenia: very rare, postmarketing, uncommon, 1% - 3% lamotrigine
				
			lansoprazole
				
				
					Thrombocytopenia: postmarketing lasofoxifene
				
				
					Thrombocytopenia: uncommon leflunomide
				
				
					Thrombocytopenia: postmarketing, uncommon lenalidomide
				
				
					Thrombocytopenia: postmarketing, very common, 12.2% - 74% lercanidipine
				
			leucovorin
				
				
					Thrombocytopenia: 1% - 18% leuprorelin acetate
				
			levetiracetam
				
				
					Thrombocytopenia: postmarketing, common levodopa/carbidopa
				
			linezolid
				
				
					Thrombocytopenia: postmarketing, 0% - 4.7% lomefloxacin
				
			lomustine
				
			lorazepam
				
				
					Thrombocytopenia: postmarketing losartan
				
				
					Thrombocytopenia: postmarketing lovastatin
				
				
					Thrombocytopenia: postmarketing loxapine
				
			lymecycline
				
			maprotiline
				
			medroxyprogesterone acetate
				
			mefenamic acid
				
			mefloquine
				
				
					Thrombocytopenia: postmarketing melatonin
				
			meloxicam
				
			melphalan
				
				
					Thrombocytopenia: very common memantine
				
				
					Thrombocytopenia: postmarketing mephenytoin
				
			meropenem
				
			mesna
				
			metformin
				
			methadone
				
			methimazole
				
			methotrexate
				
			methyclothiazide
				
			methyldopa
				
			methylphenidate
				
				
					Thrombocytopenia: very rare, postmarketing methysergide
				
			metolazone
				
			metoprolol
				
				
					Thrombocytopenia: very rare, postmarketing metronidazole
				
			mexiletine
				
			mianserin
				
			miglustat
				
				
					Thrombocytopenia: 5% - 7% milnacipran
				
				
					Thrombocytopenia: postmarketing milrinone
				
			minocycline
				
				
					Thrombocytopenia: postmarketing minoxidil
				
			mirtazapine
				
				
					Thrombocytopenia: postmarketing, rare misoprostol
				
				
					Thrombocytopenia: postmarketing mitomycin C
				
			mitotane
				
			mitoxantrone
				
			montelukast
				
				
					Thrombocytopenia: postmarketing morphine
				
			moxifloxacin
				
			mycophenolate mofetil
				
				
					Thrombocytopenia: 3.5% - 42.2% mycophenolic acid
				
				
					Thrombocytopenia: 23.5% - 42.2% nabumetone
				
			nalidixic acid
				
			naproxen
				
				
					Thrombocytopenia: postmarketing naratriptan
				
			nebivolol
				
				
					Thrombocytopenia: postmarketing nefazodone
				
				
					Thrombocytopenia: postmarketing nelarabine
				
				
					Thrombocytopenia: 22% - 88% nelfinavir
				
			nevirapine
				
			nicardipine
				
			nicorandil
				
			nifedipine
				
			nilotinib
				
				
					Thrombocytopenia: very common, 9% - 42% nimodipine
				
			nitric oxide
				
			nitrofurantoin
				
			nitrogen mustard
				
			nitrous oxide
				
			nizatidine
				
			norfloxacin
				
				
					Thrombocytopenia: postmarketing nortriptyline
				
			ofatumumab
				
			ofloxacin
				
				
					Thrombocytopenia: postmarketing olanzapine
				
				
					Thrombocytopenia: very rare, postmarketing, infrequent olmesartan
				
			olsalazine
				
			omeprazole
				
				
					Thrombocytopenia: postmarketing, rare oseltamivir
				
				
					Thrombocytopenia: postmarketing oxaliplatin
				
				
					Thrombocytopenia: postmarketing, rare, very common, 0% - 77.4% oxaprozin
				
			oxcarbazepine
				
				
					Thrombocytopenia: very rare oxprenolol
				
			oxytetracycline
				
			paclitaxel
				
				
					Thrombocytopenia: very common, 2% - 70% paliperidone
				
				
					Thrombocytopenia: very rare, postmarketing pamidronate
				
				
					Thrombocytopenia: common, 0% - 16.6% pantoprazole
				
				
					Thrombocytopenia: very rare, postmarketing parecoxib
				
			paroxetine
				
				
					Thrombocytopenia: very rare, postmarketing, rare pazopanib
				
				
					Thrombocytopenia: 1% - 36% pemetrexed
				
				
					Thrombocytopenia: 0% - 27% penciclovir
				
				
					Thrombocytopenia: postmarketing penicillin
				
			penicillin V
				
			pentamidine
				
			pentosan polysulfate
				
			pentostatin
				
				
					Thrombocytopenia: 6% - 32% pentoxifylline
				
			pergolide
				
				
					Thrombocytopenia: infrequent perindopril
				
				
					Thrombocytopenia: very rare perindopril erbumine
				
				
					Thrombocytopenia: postmarketing perindoprilat
				
				
					Thrombocytopenia: postmarketing phenylbutyric acid
				
			phenytoin
				
				
					Thrombocytopenia: infrequent pilocarpine
				
			piperacillin
				
			piroxicam
				
			pixantrone
				
			polythiazide
				
			pomalidomide
				
				
					Thrombocytopenia: 1.7% - 27% ponatinib
				
				
					Thrombocytopenia: 4% - 47% posaconazole
				
			pralatrexate
				
			pramipexole
				
			prasugrel
				
				
					Thrombocytopenia: postmarketing pravastatin
				
				
					Thrombocytopenia: postmarketing pregabalin
				
				
					Thrombocytopenia: infrequent procainamide
				
			procaine penicillin
				
			procarbazine
				
			prochlorperazine
				
			promethazine
				
			propafenone
				
				
					Thrombocytopenia: postmarketing propylthiouracil
				
			prostacyclin
				
			protriptyline
				
			pyrazinamide
				
			pyrimethamine
				
			quetiapine
				
			quinapril
				
			quinaprilat
				
			quinidine
				
			rabeprazole
				
				
					Thrombocytopenia: postmarketing radium
				
				
					Thrombocytopenia: 2% - 31% raloxifene
				
				
					Thrombocytopenia: uncommon raltegravir
				
				
					Thrombocytopenia: postmarketing raltitrexed
				
			ramipril
				
			ramiprilat
				
			ranitidine
				
			ranolazine
				
			rapamycin
				
				
					Thrombocytopenia: 7% - 30% rasburicase
				
			regorafenib
				
			remifentanil
				
				
					Thrombocytopenia: 0% - 2.44% repaglinide
				
			retigabine
				
			retinoic acid
				
				
					Thrombocytopenia: postmarketing ribavirin
				
				
					Thrombocytopenia: common, 1% - 8% rifabutin
				
			rifampicin
				
			rifapentine
				
			riluzole
				
			risperidone
				
				
					Thrombocytopenia: postmarketing, rare ritonavir
				
			rivastigmine
				
				
					Thrombocytopenia: infrequent, frequent rofecoxib
				
			ropinirole
				
				
					Thrombocytopenia: infrequent, frequent ropivacaine
				
			rosiglitazone
				
			rosuvastatin
				
				
					Thrombocytopenia: postmarketing rufinamide
				
				
					Thrombocytopenia: infrequent ruxolitinib
				
				
					Thrombocytopenia: very common, 3.9% - 69.8% samarium
				
			saquinavir
				
			sertraline
				
				
					Thrombocytopenia: postmarketing, rare sevoflurane
				
			sibutramine
				
			silver sulfadiazine
				
			simvastatin
				
				
					Thrombocytopenia: postmarketing sitaxsentan
				
			sorafenib
				
				
					Thrombocytopenia: postmarketing, common sotalol
				
				
					Thrombocytopenia: postmarketing sparfloxacin
				
				
					Thrombocytopenia: postmarketing spironolactone
				
			stavudine
				
				
					Thrombocytopenia: very rare, postmarketing stiripentol
				
			streptomycin
				
			streptozotocin
				
			sulfadiazine
				
			sulfamethoxazole
				
			sulfasalazine
				
			sulindac
				
			sumatriptan
				
				
					Thrombocytopenia: postmarketing sunitinib
				
				
					Thrombocytopenia: postmarketing, 1% tacrolimus
				
				
					Thrombocytopenia: common, 14% - 24% tamoxifen
				
			telavancin
				
				
					Thrombocytopenia: uncommon telmisartan
				
				
					Thrombocytopenia: postmarketing, rare temazepam
				
			temozolomide
				
				
					Thrombocytopenia: common, very common, 0% - 9% temsirolimus
				
			teniposide
				
			tenofovir disoproxil fumarate
				
				
					Thrombocytopenia: postmarketing tenoxicam
				
			terazosin
				
				
					Thrombocytopenia: postmarketing terbinafine
				
				
					Thrombocytopenia: very rare, postmarketing testosterone
				
				
					Thrombocytopenia: postmarketing tetracycline
				
			thalidomide
				
				
					Thrombocytopenia: 0% - 11.3% thiazide
				
			thioridazine
				
				
					Thrombocytopenia: postmarketing thiotepa
				
			thiothixene
				
			thymidine
				
				
					Thrombocytopenia: 0% - 1% tiagabine
				
				
					Thrombocytopenia: infrequent tiaprofenic acid
				
			ticlopidine
				
			tigecycline
				
				
					Thrombocytopenia: postmarketing, uncommon tinidazole
				
			tiopronin
				
			tipranavir
				
				
					Thrombocytopenia: uncommon tirofiban
				
				
					Thrombocytopenia: postmarketing tizanidine
				
			tobramycin
				
			tolazamide
				
			tolbutamide
				
			tolcapone
				
			tolmetin
				
			topiramate
				
				
					Thrombocytopenia: postmarketing, 1% topotecan
				
				
					Thrombocytopenia: postmarketing, common, very common, 0.5% - 81% Thrombocytopenia aggravatedtorasemide
				
				
					Thrombocytopenia: postmarketing toremifene
				
			trabectedin
				
			tramadol
				
				
					Thrombocytopenia: postmarketing, uncommon trametinib
				
				
					Thrombocytopenia: 0% - 31% trandolapril
				
			trandolaprilat
				
				
					Thrombocytopenia: postmarketing tranylcypromine
				
			treprostinil
				
				
					Thrombocytopenia: postmarketing triamterene
				
			trimethadione
				
			trimethoprim
				
				
					Thrombocytopenia: very rare trimethoprim-sulfamethoxazole
				
				
					Thrombocytopenia: very rare trimetrexate
				
				
					Thrombocytopenia: 0% - 33.3% trimipramine
				
			trovafloxacin
				
			v 1784
				
				
					Thrombocytopenia: postmarketing, uncommon valdecoxib
				
			valganciclovir
				
				
					Thrombocytopenia: 3% - 5% valproate
				
				
					Thrombocytopenia: 1% - 24% valsartan
				
				
					Thrombocytopenia: postmarketing vandetanib
				
			varenicline
				
			venlafaxine
				
				
					Thrombocytopenia: rare, infrequent vinblastine
				
			vincristine
				
			vinflunine
				
			vinorelbine
				
				
					Thrombocytopenia: 0% - 21% voriconazole
				
				
					Thrombocytopenia: common, 0% - 1.08% vorinostat
				
			x M22
				
			zafirlukast
				
			zalcitabine
				
			zidovudine
				
				
					Thrombocytopenia: uncommon, 0% - 3% zidovudine/lamivudine
				
			ziprasidone
				
			zoledronic acid
				
				
					Thrombocytopenia: uncommon zolmitriptan
				
			zonisamide
				
			zuclopenthixol
				
			 | Drugs with this indication |